Selective Uptake Into Inflamed Human Intestinal Tissue and Immune Cell Targeting by Wormlike Polymer Micelles

Inflammatory bowel disease (IBD) has become a globally prevalent chronic disease with no causal therapeutic options. Targeted drug delivery systems with selectivity for inflamed areas in the gastrointestinal tract promise to reduce severe drug-related side effects. By creating three distinct nanostructures (vesicles, spherical, and wormlike micelles) from the same amphiphilic block copolymer poly(butyl acrylate)-block-poly(ethylene oxide) (PBA-b-PEO), the effect of nanoparticle shape on human mucosal penetration is systematically identified. An Ussing chamber technique is established to perform the ex vivo experiments on human colonic biopsies, demonstrating that the shape of polymeric nanostructures represents a rarely addressed key to tissue selectivity required for efficient IBD treatment. Wormlike micelles specifically enter inflamed mucosa from patients with IBD, but no significant uptake is observed in healthy tissue. Spheres (approximate to 25 nm) and vesicles (approximate to 120 nm) enter either both normal and inflamed tissue types or do not penetrate any tissue. According to quantitative image analysis, the wormlike nanoparticles localize mainly within immune cells, facilitating specific targeting, which is crucial for further increasing the efficacy of IBD treatment. These findings therefore demonstrate the untapped potential of wormlike nanoparticles not only to selectively target the inflamed human mucosa, but also to target key pro-inflammatory cells. Wormlike polymer micelles are found to translocate selectively into inflamed intestinal mucosa without affecting healthy tissue, while other shapes show no or similar uptake in both tissues. Entering the lamina propria, the micelles further passively target only the immune cells of the inflamed biopsy, which is key for effective treatment of inflammatory bowel disease (IBD) and elimination of drug-related side effects.image

Automated summary

Inflammatory bowel disease (IBD) is a globally prevalent chronic disease with no causal therapeutic options. This study demonstrates the potential of wormlike nanoparticles in selectively targeting inflamed human mucosa and pro-inflammatory cells. The shape of the nanoparticles plays a crucial role in tissue selectivity for efficient IBD treatment.